Skip to main content
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
52.06
+1.07 (2.10%)
At close: Apr 28, 2026, 4:00 PM EDT
51.97
-0.09 (-0.17%)
Pre-market: Apr 29, 2026, 6:04 AM EDT

CRISPR Therapeutics AG Revenue

In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%. CRISPR Therapeutics AG had revenue of $864.00K in the quarter ending December 31, 2025, a decrease of -97.58%.

Revenue (ttm)
$3.51M
Revenue Growth
-90.59%
P/S Ratio
1,428.57
Revenue / Employee
$8,931
Employees
393
Market Cap
5.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.51M-33.80M-90.59%
Dec 31, 202437.31M-333.89M-89.95%
Dec 31, 2023371.21M370.01M30,885.48%
Dec 31, 20221.20M-913.77M-99.87%
Dec 31, 2021914.96M914.24M127,154.94%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Legend Biotech 1.03B
Apellis Pharmaceuticals 1.00B
Corcept Therapeutics 761.41M
Amicus Therapeutics 634.21M
TG Therapeutics 616.29M
Mirum Pharmaceuticals 521.31M
Ligand Pharmaceuticals 268.09M
Crinetics Pharmaceuticals 7.70M
Revenue Rankings

CRSP News

More News